Hydroxyurea Toxicity in Human Immunodeficiency Virus-Positive Patients

Goodrich, James; Khardori, Nancy
September 1999
Clinical Infectious Diseases;9/1/1999, Vol. 29 Issue 3, p692
Academic Journal
Reports two cases of hydroxyurea toxicity in HIV-positive men. Discussion on the use of hydroxyurea for the treatment of HIV disease and its main side effects; Details of two cases in which the use of hydroxyurea was stopped due to its side effects; Significant effect of hydroxyurea.


Related Articles

  • Internet-Facilitated, Voluntary Counseling and Testing (VCT) Clinic-Based HIV Testing among Men Who Have Sex with Men in China. Zou, Huachun; Wu, Zunyou; Yu, Jianping; Li, Min; Ablimit, Muhtar; Li, Fan; Poundstone, Katharine // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Objective: To explore the feasibility of using Internet outreach to encourage men who have sex with men (MSM) to get tested for HIV at voluntary counseling and testing (VCT) clinics in Beijing and Urumqi, China. Methods: From June to August 2007, two volunteers contacted MSM using instant...

  • The Effects of Protease Inhibitor Therapy on Human Immunodeficiency Virus Type 1 Levels in Semen... Eron Jr., Joseph J.; Smeaton, Laura M.; Fiscus, Susan A.; Gulick, Roy M.; Currier, Judith S.; Lennox, Jeffrey L.; D'Aquila, Richard T.; Rogers, Michael D.; Tung, Roger; Murphy, Robert L. // Journal of Infectious Diseases;5/1/2000, Vol. 181 Issue 5, p1622 

    Examines the effects of protease inhibitor therapy on HIV-type 1 levels in semen. Decreased shedding of HIV-type 1 in genital secretions by antiretroviral therapy; HIV-type 1 RNA levels in seminal plasma during amprenavir, zidovudine and lamivudine.

  • MK-1439 shows promise in treatment-naive males with HIV. Henry, Jennifer; Schoen, John; Shafer, Emily // Infectious Disease News;Apr2013, Vol. 26 Issue 4, p23 

    The article discusses a study presented at the 2013 Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta, Georgia which found that MK-1439, a non-nucleoside reverse transcriptase inhibitor, is effective in treating naive male patients with HIV infection.

  • Confronting the rarest AIDS infection, a young man makes a cry from the heart. Breo, Dennis L.; Breo, D L // JAMA: Journal of the American Medical Association;9/8/89, Vol. 262 Issue 10, p1383 

    Reports on the case of a 32-year-old American man who acquired HIV following a bus accident in Rwanda in December 1987. Exposure of the man to the blood of similarly injured passengers; Relatively high seroprevalence rates for the AIDS virus in blood donors from Rwanda; Health status before the...

  • Severe Crohn's Disease in a HIV-HCv Co-Infected Man. Olalla, Julian; de la Torre, Javier; Arco, Alfonso del; Navarro, Jose M.; Fernandez, Francisco; Prada, Jose Luis; Garcia-Alegria, Javier // Journal of AIDS & Clinical Research;2012, Vol. 3 Issue 5, Special section p1 

    The article describes the case of a 47-year-old HIV-positive man who developed severe Crohn's disease. The patient received anti-retroviral drugs for his condition, including pegylated interferon and ribavirin. Capsule endoscopy revealed his Crohn's disease. He was given treatment with...

  • The Progression of Untreated HIV-1 Infection Prior to AIDS. Hoover, Donald R.; Saah, Alfred; Bacellar, Helena; Murphy, Robert; Visscher, Barbara; Metz, Sharon; Anderson, Roger; Kaslow, Richard A. // American Journal of Public Health;Nov92, Vol. 82 Issue 11, p1538 

    Using a case-control study of untreated men, we investigated the physical, mental, and economic effects of human immunodeficiency virus (HIV-1) infection prior to the diagnosis of acquired immunodeficiency syndrome (AIDS). Beginning 2 to 2.5 years prior to AIDS, case subjects reported more of 12...

  • Federal Trial Judge in New York Refuses to Dismiss HIV+ Plaintiff's ADA Claim. A. S. L. // Lesbian -- Gay Law Notes;Mar2006, p49 

    The article reports on the ruling of U.S. District Judge Gerard E. Lynch that Clifford Teachout's HIV-positive status did qualify for statutory protection from discrimination under the Americans With Disabilities Act. To qualify, Teachout need to identify some major life activity that was...

  • High prevalence of high risk human papillomavirus-capsid antibodies in human immunodeficiency virus-seropositive men: a serological study. Höfl, Reinhard; Petter, Anton; Thaler, Petra; Sarcletti, Mario; Widschwendter, Andreas; Zangerle, Robert // BMC Infectious Diseases;2003, Vol. 3 Issue 1, p6 

    Background: Serological study of human papillomavirus (HPV)-antibodies in order to estimate the HPV-prevalence as risk factor for the development of HPV-associated malignancies in human immunodeficiency virus (HIV)-positive men. Methods: Sera from 168 HIV-positive men and 330 HIV-negative...

  • Prevalence and Correlates of Untreated Human Immunodeficiency Virus Type 1 Infection among Persons Who Have Died in the Era of Modern Antiretroviral Therapy. Wood, Evan; Montaner, Julio S. G.; Tyndall, Mark W.; Schechter, Martin T.; O'Shaughnessy, Michael V.; Hogg, Robert S. // Journal of Infectious Diseases;10/15/2003, Vol. 188 Issue 8, p1164 

    We evaluated all human immunodeficiency virus (HIV)-related deaths over the period 1 January 1995-31 December 2001 in a Canadian province in which all HIV care and antiretroviral therapy are provided free of charge. Persons who had received antiretroviral drugs before death were compared with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics